Management of Small Gallbladder Polyps

Risk Stratification Based on Size and Morphology

The Society of Radiologists in Ultrasound (SRU) recommends that polyps smaller than 6 mm have an extremely low risk of malignancy, with studies showing 0% malignancy rate in polyps smaller than 5 mm 4
Population studies show cancer rates of only 1.3 per 100,000 patients for polyps smaller than 6 mm 4
The morphology of the polyp (pedunculated vs. sessile) would further stratify risk, but at small sizes, the distinction becomes less critical 3

The SRU consensus guidelines recommend no follow-up for pedunculated polyps with thin stalks ("ball-on-the-wall" appearance) if 9 mm or smaller 1, 3
The SRU consensus guidelines recommend no follow-up for sessile polyps or pedunculated polyps with thick stalks if 6 mm or smaller 3
A 2.8 mm polyp falls well below both thresholds and requires no follow-up regardless of morphology 2, 3

The EASL guidelines recommend cholecystectomy for patients with Primary Sclerosing Cholangitis (PSC) and gallbladder polyps ≥8 mm due to higher malignancy risk 6
If the polyp demonstrates rapid growth (defined as ≥4 mm growth within 12 months), reassessment would be warranted 4

Some polyps may fluctuate in size by 2-3 mm as part of their natural history, which is not concerning 7
The growth rate of benign polyps is typically very slow, with studies showing rates of 0.16-2.76 mm/year 7

Overdiagnosis and unnecessary follow-up can occur, as studies show that 61-69% of polyps seen on ultrasound are not identified at subsequent cholecystectomy, and for polyps ≤5 mm, no polyp is found at cholecystectomy in up to 83% of patients 4
Confusing tumefactive sludge with true polyps can occur, as small echogenic non-mobile lesions may represent sludge rather than true polyps 2
Recognizing that malignancy risk is virtually zero for polyps <5 mm helps prevent undue concern for patients 4